Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
7
|
| pubmed:dateCreated |
1997-9-24
|
| pubmed:language |
rus
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jul
|
| pubmed:issn |
0365-9615
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
124
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
39-42
|
| pubmed:dateRevised |
2008-10-8
|
| pubmed:meshHeading |
pubmed-meshheading:9303728-Adrenocorticotropic Hormone,
pubmed-meshheading:9303728-Animals,
pubmed-meshheading:9303728-Brain Ischemia,
pubmed-meshheading:9303728-Cerebrovascular Circulation,
pubmed-meshheading:9303728-Injections, Intraperitoneal,
pubmed-meshheading:9303728-Male,
pubmed-meshheading:9303728-Peptide Fragments,
pubmed-meshheading:9303728-Rats
|
| pubmed:year |
1997
|
| pubmed:articleTitle |
[Relationship between the therapeutic effect of the peptide preparation semax and the severity of brain ischemia].
|
| pubmed:publicationType |
Journal Article
|